- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04919005
Virtual Environment to Aid Cognitive Stimulation of Elderly People With Early Alzheimer's
June 2, 2021 updated by: Terigi Augusto Scardovelli, University of Mogi das Cruzes
This research was carried out with the objective of verifying the possibility of intervention through cognitive training protocols to assist in the stimulation of neurons and to delay the degradation resulting from Alzheimer's disease in its initial phase.
The specific objective of this research was to develop and validate a virtual environment of games (called SorrisoTur) that allows the intervention of cognitive training.
Study Overview
Detailed Description
SorrisoTur encompasses cognitive training concepts and protocols in playful situations, which were coded in the form of 2D mini-games that are run on a computer connected to the Web, and designed to stimulate cognitive domains, such as memory, executive functions, spatial-visual skills, language (expression, comprehension, reading, and writing) and personality/behavior.
For the comparison of results, three groups were created; one group of elderly people with Alzheimer's disease at an early stage, one group formed by healthy elderly, and another group with young people and applied Mini-Mental State Examination (MMSE) and Wechsler Intelligence Scale for Adults (WAIS-III) before and after of interventions with the games.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Mogi das Cruzes, São Paulo, Brazil, 08780-911
- Terigi Augusto Scardovelli
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- People with physical or psychological conditions allow interacting with digital games;
- Elderly over 60 years with mild Alzheimer;
- Seniors over 60 Healthy;
- Healthy Youth;
Exclusion Criteria:
- People without physical or psychological conditions allow interacting with digital games;
- Elderly people over 60 years old who have any type of dementia other than Alzheimer, or moderate or severe Alzheimer;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy elderly people
Twelve healthy elderly people.
Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.
|
The Virtual Environment was called SorrisoTur and consists of 10 mini-games with difficulty levels in a limited number of cities and mini-games distributed in a thematic scenario of the map of Brazil.
The virtual environment consists of the cognitive training mini-games within a theme for all screens, mini-games, and information.
The interventions with the Virtual Environment were administered in periods of one hour, twice a week, for a month.
|
|
Experimental: Elderly people with Alzheimer's in the initial phase
Seven elderly people with Alzheimer's in the initial phase.
Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.
|
The Virtual Environment was called SorrisoTur and consists of 10 mini-games with difficulty levels in a limited number of cities and mini-games distributed in a thematic scenario of the map of Brazil.
The virtual environment consists of the cognitive training mini-games within a theme for all screens, mini-games, and information.
The interventions with the Virtual Environment were administered in periods of one hour, twice a week, for a month.
|
|
Experimental: Healthy young people
Fifteen healthy young people.
Each participant underwent a pre-test, the intervention with a Virtual Environment, and a post-test.
|
The Virtual Environment was called SorrisoTur and consists of 10 mini-games with difficulty levels in a limited number of cities and mini-games distributed in a thematic scenario of the map of Brazil.
The virtual environment consists of the cognitive training mini-games within a theme for all screens, mini-games, and information.
The interventions with the Virtual Environment were administered in periods of one hour, twice a week, for a month.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on Wechsler Intelligence Scale for Adults (WAIS-III)
Time Frame: Baseline and after 4 weeks
|
The WAIS-III is an intellectual assessment that aims to analise the measures of the following Factorial Scales and Indexes: Verbal IQ (intelligence quotient), Execution IQ, Total IQ, Verbal Understanding Index, Perceptual Organization Indexes, Operational Memory Indexes and Processing speed index.
|
Baseline and after 4 weeks
|
|
Change on Mini Mental State Examination (MMSE)
Time Frame: Baseline and after 4 weeks
|
The MMSE is a data collection instrument widely used in cases of dementia, it evaluates temporal and spatial orientation, short-term memory (immediate or attention) and skills of evocation, calculation, praxis, visuospatial, communication and language.
|
Baseline and after 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marcia A Bissaco, PhD, University of Mogi das Cruzes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
April 30, 2017
Study Completion (Actual)
July 20, 2017
Study Registration Dates
First Submitted
June 2, 2021
First Submitted That Met QC Criteria
June 2, 2021
First Posted (Actual)
June 9, 2021
Study Record Updates
Last Update Posted (Actual)
June 9, 2021
Last Update Submitted That Met QC Criteria
June 2, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE: 54290416.9.0000.5497
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
-
Xuanwu Hospital, BeijingEnrolling by invitation
-
Beijing Tiantan HospitalNot yet recruiting
-
Danyang Huichuang Medical Equipment Co., Ltd.RecruitingAlzheimer s DiseaseChina
Clinical Trials on Virtual Environment
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of ManchesterUnknownTreatment of Visual VertigoUnited Kingdom
-
The Cleveland ClinicMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson Disease | Virtual Reality | Freezing of Gait | Deep Brain Stimulation | DBSUnited States
-
Pôle Saint HélierHopital La MusseCompleted
-
University of ManchesterWithdrawnPhantom Limb Syndrome With PainUnited Kingdom
-
University Rehabilitation Institute, Republic of...CompletedMultiple Sclerosis | Parkinson DiseaseSlovenia
-
University Rehabilitation Institute, Republic of...European Regional Development Fund; Slovenian Research AgencyCompletedParkinson DiseaseSlovenia
-
Superior UniversityRecruitingParkinson DeseasePakistan
-
Cambridge University Hospitals NHS Foundation TrustUnknownStroke | Osteoarthritis | Back Pain | Sciatica | Fibromyalgia | Complex Regional Pain Syndromes | Traumatic Brain InjuryUnited Kingdom
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of Mogi das CruzesCompleted